Epstein-Barr virus in Hodgkin's disease: frequency of a 30-bp deletion in the latent membrane protein 1 (LMP-
Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene
✍ Scribed by Rita Mariel Correa; María Dolores Fellner; Lidia Virginia Alonio; Karina Durand; Angélica R. Teyssié; María Alejandra Picconi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 121 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
There are two types of Epstein Barr virus (EBV): EBV‐1 and EBV‐2, distinguished by genomic polymorphism in the genes encoding the nuclear antigens (EBNA‐2, ‐3A, ‐3B, ‐3C). Latent membrane protein 1 (LMP‐1) is an EBV protein with known oncogenic properties. Different variants had been described; among them, a 30 base pair (bp) deletion (del‐LMP‐1) had been reported in benign and malignant pathologies, but there is little information about its frequency in healthy populations. The aim of this study was to determine the distribution of the EBV genotypes and the 30 bp deletion frequency, in EBV healthy carriers from Argentina. Analysis of EBNA‐3C and LMP‐1 genes were done by polymerase chain reaction (PCR) followed by Southern blot hybridization on DNA of peripheral blood mononuclear cells (PBMCs) from blood bank donors. EBV‐1 was present in 75.9% of samples, EBV‐2 in 14.6%, and co‐infections with both types in 6.5%. The deleted LMP‐1 variant was found in 7.4% of analyzed samples, corresponding 3.2% to deleted variant alone and 4.2% to co‐infections with non‐deleted form. The non‐deleted variant was found in 64.6% whereas in the remaining 28%, no PCR product was detected. These results showed that EBV‐1 was the more prevalent type in healthy carriers of Argentina, similar to reports from others countries. A predominance of the non‐deleted LMP‐1 variant was observed. The presence of co‐infections with both types and variants demonstrated that healthy individuals may also harbor multiple EBV infections. J. Med. Virol. 73:583–588, 2004. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A large group of juvenile Hodgkin's disease patients (n = 242, mean age 11.7 years, 75% [n = 181] seropositive) was evaluated for anti‐Epstein‐Barr virus (EBV) antibody responses and the presence of EBV‐encoded EBER‐RNA and latent membrane protein‐1 (LMP1)‐protein expression in the tumo
A specific variant of Epstein-Barr virus (EBV) with a 30-bp deletion in the C-terminal region of the LMP1 gene has been found in some EBV-associated malignancies. To better understand the tumorigenic role of this LMP1 variant, we used PCR and sequencing to examine the LMP1 gene in 38 EBVassociated c
## Abstract Latent membrane protein 1 (LMP‐1) is an Epstein‐Barr virus‐encoded oncoprotein expressed in ∼50–70% of nasopharyngeal carcinoma (NPC). Previous studies have shown that NPC‐derived LMP‐1 variants carrying 30 bp deletion and specific mutations in the 3′C‐terminal region confer high oncoge
## Abstract Nasopharyngeal carcinoma, a malignancy associated closely with Epstein‐Barr virus (EBV), is prevalent among Chinese of Southern China origin. Epidemiological studies indicate a high prevalence of EBV in Asia with viral isolates having typical characteristics of the putative viral oncoge
The 30-base pair (bp) deletion of the cytoplasmic carboxy-terminal domain of the latent membrane protein 1 (LMP-1) gene was analyzed in 37 frozen tissues from patients with Epstein-Barr virus (EBV)-related gastric cancer and 18 throat washings from healthy adults in southern Japan. The 30-bp deletio